Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
NCT06894602 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-03-20
Summary
Ultrasound evaluation of the temporal and axillary arteries is currently well recognized in the field of giant cell arteritis (GCA), a disease primarily affecting medium- and large-caliber vessels. Structural ultrasound abnormalities are now well described in this pathology, but their association with relapse and clinical concordance is unknown. There is currently a follow-up score (the OGUS score) for medium- and large-caliber arteries that could also predict the clinical course of the disease.
Conditions
- Giant Cell Arteritis
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-05
- Primary Completion
- 2028-08-01
- Completion
- 2028-08-01
Countries
- France
Study Locations
More Related Trials
-
Contrast-Enhanced US of Spleen, Liver and Kidney
NCT00190281 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
NCT03725202 ·Status: COMPLETED ·Phase: PHASE3
-
Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients
NCT07060274 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis
NCT06742671 ·Status: RECRUITING
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
NCT04664465 ·Status: RECRUITING
-
Biomarkers in Giant Cells Arteritis
NCT02844023 ·Status: TERMINATED ·Phase: NA
-
Giant Cell Arteritis - Ways to Precision Medicine
NCT07084480 ·Status: RECRUITING
-
Detection of Subclinical Enthesitis by Ultrasonography
NCT04209894 ·Status: COMPLETED
-
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892 ·Status: RECRUITING ·Phase: NA
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Circulating Microparticles in Giant Cell Arteritis
NCT02333708 ·Status: UNKNOWN
-
Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis
NCT03711448 ·Status: COMPLETED ·Phase: PHASE2
-
Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein
NCT03345537 ·Status: COMPLETED
-
Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
NCT02863588 ·Status: TERMINATED ·Phase: NA
-
The Role of the Coagulation Pathways in Recurrent Angioedema
NCT02892682 ·Status: TERMINATED ·Phase: NA
-
Ustekinumab for the Treatment of Giant Cell Arteritis
NCT02955147 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
NCT01400464 ·Status: UNKNOWN ·Phase: PHASE4
-
Hydroxychloroquine in Giant Cell Arteritis
NCT00430807 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis
NCT03920722 ·Status: COMPLETED ·Phase: PHASE3
-
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
NCT00315497 ·Status: COMPLETED
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Giant Cell Arteritis and Anakinra Trial
NCT02902731 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
NCT03192969 ·Status: WITHDRAWN ·Phase: PHASE3
-
Bosentan in the Treatment of Giant Cell Arteritis
NCT06957002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2